XT
CELZ icon

XTX Topco’s Creative Medical Technology CELZ Stock Holding History

XTX Topco’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.5K Buy
26,559
+12,299
+86% +$26.5K ﹤0.01% 3772
2026
Q1 		$29.4K Buy
+14,260
New +$27.9K ﹤0.01% 3457
2022
Q2 		– Sell
-1,749
Closed -$68K – 877
2022
Q1 		$68K Buy
+1,749
New +$38.9K 0.03% 561

Other funds holding CELZ

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

XTX Topco's CELZ Position: Q2 2026 in Review

XTX Topco increased its Creative Medical Technology (CELZ) stake by 86% in Q2 2026, buying an estimated $26.5K and bringing the position to 26,559 shares worth $38.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3772.

XTX Topco first reported a position in CELZ in Q1 2022 and has held it in 3 quarters since. The position peaked at $68K in Q1 2022. 15 funds tracked by Wall St. Rank hold CELZ as of Q2 2026.

  • XTX Topco held 26,559 shares of Creative Medical Technology worth $38.5K as of Q2 2026.
  • XTX Topco bought 12,299 Creative Medical Technology shares in Q2 2026, an estimated $26.5K.
  • Creative Medical Technology made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3772 holding.
  • XTX Topco first reported a position in Creative Medical Technology in Q1 2022 and has held it in 3 quarters since.
  • XTX Topco's Creative Medical Technology position peaked at $68K in Q1 2022.
  • 15 funds tracked by Wall St. Rank held Creative Medical Technology as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.